Curaleaf joins the FTSE Canada All Cap Index
The benchmark measures large-, mid- and small-capitalization companies listed in Canada, following Curaleaf’s September 2025 S&P/TSX Composite Index inclusion.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Curaleaf Holdings, Inc. (CURLF) was added to the FTSE Canada All Cap Index, effective after the close of trading on September 18, 2026. The index measures the performance of large-, mid- and small-capitalization companies listed in Canada.
This is Curaleaf’s second major Canadian benchmark inclusion, following its addition to the S&P/TSX Composite Index under the Health Care sector in September 2025.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Effective index inclusion: September 18, 2026
Canadian benchmark inclusions: 2 major benchmarks
Prior benchmark inclusion: September 2025
3 metrics
Effective index inclusion
September 18, 2026
Effective after the close of trading
Canadian benchmark inclusions
2 major benchmarks
The FTSE Canada All Cap Index is Curaleaf’s second major Canadian benchmark inclusion
Prior benchmark inclusion
September 2025
S&P/TSX Composite Index, under the Health Care sector
Key Terms
FTSE Canada All Cap Index, S&P/TSX Composite Index, passive and active institutional funds
3 terms
FTSE Canada All Cap Index technical
"added to the FTSE Canada All Cap Index"
S&P/TSX Composite Index technical
"addition to the S&P/TSX Composite Index"
The S&P/TSX Composite Index is the main measure of how well large and mid-sized companies listed on Canada’s Toronto Stock Exchange are doing, with bigger companies carrying more influence on the score. Investors use it like a yardstick or benchmark to track the overall health of Canadian stocks, compare fund performance, and guide buying or selling decisions, much like checking an overall temperature before planning actions.
passive and active institutional funds financial
"a new set of passive and active institutional funds"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When did CURLF join the FTSE Canada All Cap Index?
Curaleaf became part of the FTSE Canada All Cap Index after the close of trading on September 18, 2026.
What companies does the FTSE Canada All Cap Index measure?
The index measures the performance of large-, mid- and small-capitalization companies listed in Canada.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): September 23, 2026
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
(Address of principal executive offices and zip code) | ||||||||
( 917 ) 717 - 5875 | ||||||||
(Registrant's telephone number, including area code) | ||||||||
(Former name or former address, if changed since last report) | ||||||||
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
On September 23, 2026, Curaleaf Holdings, Inc. issued a press release announcing its addition to the FTSE Canada All Cap Index, a copy of which is attached as Exhibit 99.1.
The information contained in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number | Description | |||||||
99.1 | Press release dated September 23, 2026 | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CURALEAF HOLDINGS, INC. | |||||||||||
(Registrant) | |||||||||||
Date: | September 23, 2026 | By: | /s/ Peter Clateman | ||||||||
Name: | Peter Clateman | ||||||||||
Title: | Chief Legal Officer | ||||||||||
Curaleaf Holdings, Inc. Investor Relations Curaleaf Added to FTSE Canada All Cap Index This addition marks the second major Canadian benchmark inclusion following the Company's addition to the S&P/TSX Composite Index in 2025 STAMFORD, Conn., Sept. 23, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has been added to the FTSE Canada All Cap Index, effective after the close of trading on Friday, September 18, 2026. "A year ago, we became the first U.S.-based cannabis operator in the S&P/TSX Composite Index. Joining the FTSE Canada All Cap Index now puts Curaleaf in a second major Canadian benchmark," said Boris Jordan, Chairman and CEO of Curaleaf. "Every index we join brings our shares in front of a new set of passive and active institutional funds, which means more liquidity, a broader shareholder base, and more investors paying attention to what U.S. cannabis can be." The FTSE Canada All Cap Index, maintained by FTSE Russell, measures the performance of large-, mid- and small- capitalization companies listed in Canada. This is the second major Canadian index fund Curaleaf has joined since the company was added to the S&P/TSX Composite Index under the Health Care sector in September 2025. About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com. Forward Looking Statements This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the inclusion in the FTSE Canada All Cap Index. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is discussed in the Company's Form 8-K dated August 5, 2026 together with the annual report on Form 10-K for the year ended December 31, 2025 and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, attached as exhibits thereto, as well as the Form 10-Q for the quarter ended June 30, 2026, each of which documents have been filed on the Company's EDGAR profile at www.sec.gov/edgar and SEDAR+ profile at www.sedarplus.ca, and as described from time to time in documents filed by the Company with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities. Forward- looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release. Investor Contact: Curaleaf Holdings, Inc. Camilo Lyon, Chief Investment Officer IR@curaleaf.com Media Contact: MATTIO Communications MattioCuraleaf@Mattio.com
SOURCE Curaleaf Holdings, Inc. https://ir.curaleaf.com/2026-09-23-Curaleaf-Added-to-FTSE-Canada-All-Cap-Index